Literature DB >> 11237866

Effect of human acetylcholinesterase subunit assembly on its circulatory residence.

T Chitlaru1, C Kronman, B Velan, A Shafferman.   

Abstract

Sialylated recombinant human acetylcholinesterase (rHuAChE), produced by stably transfected cells, is composed of a mixed population of monomers, dimers and tetramers and manifests a time-dependent circulatory enrichment of the higher-order oligomeric forms. To investigate this phenomenon further, homogeneous preparations of rHuAChE differing in their oligomerization statuses were generated: (1) monomers, represented by the oligomerization-impaired C580A-rHuAChE mutant, (2) wild-type (WT) dimers and (3) tetramers of WT-rHuAChE generated in vitro by complexation with a synthetic ColQ-derived proline-rich attachment domain ('PRAD') peptide. Three different series of each of these three oligoform preparations were produced: (1) partly sialylated, derived from HEK-293 cells; (2) fully sialylated, derived from engineered HEK-293 cells expressing high levels of sialyltransferase; and (3) desialylated, after treatment with sialidase to remove sialic acid termini quantitatively. The oligosaccharides associated with each of the various preparations were extensively analysed by matrix-assisted laser desorption ionization-time-of-flight MS. With the enzyme preparations comprising the fully sialylated series, a clear linear relationship between oligomerization and circulatory mean residence time (MRT) was observed. Thus monomers, dimers and tetramers exhibited MRTs of 110, 195 and 740 min respectively. As the level of sialylation decreased, this differential behaviour became less pronounced; eventually, after desialylation all oligoforms had the same MRT (5 min). These observations suggest that multiple removal systems contribute to the elimination of AChE from the circulation. Here we also demonstrate that by the combined modulation of sialylation and tetramerization it is possible to generate a rHuAChE displaying a circulatory residence exceeding that of all other known forms of native or recombinant human AChE.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237866      PMCID: PMC1221693          DOI: 10.1042/0264-6021:3540613

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.

Authors:  R A Houghten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

2.  Interchain disulfide bonds and subunit organization in human serum cholinesterase.

Authors:  O Lockridge; H W Eckerson; B N La Du
Journal:  J Biol Chem       Date:  1979-09-10       Impact factor: 5.157

Review 3.  Carbohydrate-specific receptors of the liver.

Authors:  G Ashwell; J Harford
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

4.  Cellular localization of the multiple molecular forms of acetylcholinesterase in cultured neuronal cells.

Authors:  P B Taylor; F Rieger; M L Shelanski; L A Greene
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

5.  Hierarchy of post-translational modifications involved in the circulatory longevity of glycoproteins. Demonstration of concerted contributions of glycan sialylation and subunit assembly to the pharmacokinetic behavior of bovine acetylcholinesterase.

Authors:  C Kronman; T Chitlaru; E Elhanany; B Velan; A Shafferman
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

6.  Acetylcholinesterase prophylaxis against organophosphate toxicity.

Authors:  A D Wolfe; R S Rush; B P Doctor; I Koplovitz; D Jones
Journal:  Fundam Appl Toxicol       Date:  1987-08

7.  Sialylation of glycoprotein oligosaccharides N-linked to asparagine. Enzymatic characterization of a Gal beta 1 to 3(4)GlcNAc alpha 2 to 3 sialyltransferase and a Gal beta 1 to 4GlcNAc alpha 2 to 6 sialyltransferase from rat liver.

Authors:  J Weinstein; U de Souza-e-Silva; J C Paulson
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

8.  Acetylcholinesterase from fetal bovine serum. Purification and characterization of soluble G4 enzyme.

Authors:  J S Ralston; R S Rush; B P Doctor; A D Wolfe
Journal:  J Biol Chem       Date:  1985-04-10       Impact factor: 5.157

9.  Mutagenesis of human acetylcholinesterase. Identification of residues involved in catalytic activity and in polypeptide folding.

Authors:  A Shafferman; C Kronman; Y Flashner; M Leitner; H Grosfeld; A Ordentlich; Y Gozes; S Cohen; N Ariel; D Barak
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

10.  Molecular forms of acetylcholinesterase and butyrylcholinesterase in human plasma and cerebrospinal fluid.

Authors:  J R Atack; E K Perry; J R Bonham; R H Perry
Journal:  J Neurochem       Date:  1987-06       Impact factor: 5.372

View more
  11 in total

Review 1.  Cholinesterases and the fine line between poison and remedy.

Authors:  Carey N Pope; Stephen Brimijoin
Journal:  Biochem Pharmacol       Date:  2018-01-31       Impact factor: 5.858

2.  Effect of chemical modification of recombinant human acetylcholinesterase by polyethylene glycol on its circulatory longevity.

Authors:  O Cohen; C Kronman; T Chitlaru; A Ordentlich; B Velan; A Shafferman
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

3.  LARGE SCALE PURIFICATION OF BUTYRYLCHOLINESTERASE FROM HUMAN PLASMA SUITABLE FOR INJECTION INTO MONKEYS; A POTENTIAL NEW THERAPEUTIC FOR PROTECTION AGAINST COCAINE AND NERVE AGENT TOXICITY.

Authors:  Oksana Lockridge; Lawrence M Schopfer; Gail Winger; James H Woods
Journal:  J Med Chem Biol Radiol Def       Date:  2005-07-01

4.  Rescue and Stabilization of Acetylcholinesterase in Skeletal Muscle by N-terminal Peptides Derived from the Noncatalytic Subunits.

Authors:  Carlos A Ruiz; Susana G Rossi; Richard L Rotundo
Journal:  J Biol Chem       Date:  2015-07-02       Impact factor: 5.157

Review 5.  Biogenesis, assembly and trafficking of acetylcholinesterase.

Authors:  Richard L Rotundo
Journal:  J Neurochem       Date:  2017-03-21       Impact factor: 5.372

6.  Overloading and removal of N-glycosylation targets on human acetylcholinesterase: effects on glycan composition and circulatory residence time.

Authors:  Theodor Chitlaru; Chanoch Kronman; Baruch Velan; Avigdor Shafferman
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

7.  Crystallization and X-ray structure of full-length recombinant human butyrylcholinesterase.

Authors:  Michelle N Ngamelue; Kohei Homma; Oksana Lockridge; Oluwatoyin A Asojo
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-08-10

8.  The proline-rich tetramerization peptides in equine serum butyrylcholinesterase.

Authors:  Kevser Biberoglu; Lawrence M Schopfer; Ozden Tacal; Oksana Lockridge
Journal:  FEBS J       Date:  2012-09-07       Impact factor: 5.542

9.  Amino acid domains control the circulatory residence time of primate acetylcholinesterases in rhesus macaques (Macaca mulatta).

Authors:  Ofer Cohen; Chanoch Kronman; Baruch Velan; Avigdor Shafferman
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

10.  Polyproline-rich peptides associated with Torpedo californica acetylcholinesterase tetramers.

Authors:  Lilly Toker; Israel Silman; Tzviya Zeev-Ben-Mordehai; Joel L Sussman; Lawrence M Schopfer; Oksana Lockridge
Journal:  Chem Biol Interact       Date:  2020-02-20       Impact factor: 5.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.